Evaluation of ADAM-12 as a Diagnostic Biomarker of Ectopic Pregnancy in Women with a Pregnancy of Unknown Location
Open Access
- 21 August 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e41442
Abstract
Ectopic pregnancy (EP) remains the most life-threatening acute condition in modern gynaecology. It remains difficult to diagnose early and accurately. Women often present at emergency departments in early pregnancy with a ‘pregnancy of unknown location’ (PUL) and diagnosis/exclusion of EP is challenging due to a lack of reliable biomarkers. Recent studies suggest that serum levels of a disintegrin and metalloprotease protein-12 (ADAM-12) can be used differentiate EP from viable intrauterine pregnancy (VIUP). Here we describe a prospective study evaluating the performance of ADAM-12 in differentiating EP from the full spectrum of alternative PUL outcomes in an independent patient cohort. Sera were collected from 120 patients at their first clinical presentation with a PUL and assayed for ADAM-12 by ELISA. Patients were categorized according to final pregnancy outcomes. Serum ADAM-12 concentrations were increased in women with histologically-confirmed EP (median 442 pg/mL; 25%–75% percentile 232–783 pg/mL) compared to women with VIUP (256 pg/mL; 168–442 pg/mL) or miscarriage (192 pg/mL; 133–476 pg/mL). Serum ADAM-12 did not differentiate histologically-confirmed EP from spontaneously resolving PUL (srPUL) (416 pg/mL; 154–608 pg/mL). The diagnostic potential of ADAM-12 was only significant when ‘ambiguous’ PUL outcomes were excluded from the analysis (AROC = 0.6633; P = 0.03901). When measured in isolation, ADAM-12 levels had limited value as a diagnostic biomarker for EP in our patient cohort. The development of a reliable serum biomarker-based test for EP remains an ongoing challenge.Keywords
This publication has 13 references indexed in Scilit:
- Molecular diagnosis of ectopic pregnancyExpert Review of Molecular Diagnostics, 2011
- Diagnosis and management of ectopic pregnancyBMJ Sexual & Reproductive Health, 2011
- Diagnosis and management of ectopic pregnancyBMJ, 2011
- Disintegrin and metalloprotease and ectopic pregnancyFertility and Sterility, 2011
- A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancyFertility and Sterility, 2011
- The need for serum biomarker development for diagnosing and excluding tubal ectopic pregnancyActa Obstetricia et Gynecologica Scandinavica, 2010
- Economic evaluation of diagnosing and excluding ectopic pregnancyHuman Reproduction, 2009
- The diagnostic effectiveness of an initial transvaginal scan in detecting ectopic pregnancyHuman Reproduction, 2007
- ADAM 12 as a first‐trimester maternal serum marker in screening for Down syndromePrenatal Diagnosis, 2006
- The use of a new logistic regression model for predicting the outcome of pregnancies of unknown locationHuman Reproduction, 2004